Considerable effort has been devoted to the characterization of P-glycoprotein - drug interaction in the past. Systematic quantitative structure-activity relationship (QSAR) studies identified both predictive physicochemical parameters and pharmacophoric substructures within homologous series of compounds. Comparative molecular field analysis (CoMFA) led to distinct 3D-QSAR models for propafenone and phenothiazine analogs. Recently, several pharmacophore models have been generated for diverse sets of ligands. Starting from a training set of 15 propafenone-type MDR-modulators, we established a chemical function-based pharmacophore model. The pharmacophoric features identified by this model were (i) one hydrogen bond acceptor, (ii) one hydrophobic area, (iii) two aromatic hydrophobic areas, and (iv) one positive ionizable group. In silico screening of the Derwent World Drug Index using the model led to identification of 28 compounds. Substances retrieved by database screening are diverse in structure and include dihydropyridines, chloroquine analogs, phenothiazines, and terfenadine. On the basis of its general applicability, the presented 3DQSAR model allows in silico screening of virtual compound libraries to identify new potential lead compounds.

No abstract

In silico Screening with Benzofuran-and Benzopyran-Type MDR-Modulators. -The properties of the novel compounds (VII) together with the earlier synthesized benzofuran derivatives are discussed. The benzopyranones show a good correlation between lipophilicity and activity. -(REBITZER, S.; ANNIBALI, D.; KOPP, S.; EDER, M.; LANGER, T.; CHIBA, P.; ECKER*, G. F.; NOE, C. R.; Farmaco 58 (2003) 3, 185-191; Inst. Pharm. Chem., Univ. Wien, A-1090 Wien, Austria; Eng.) -K. Schneider 30-158